What is the level of liabilities of Biosenic this year?
Biosenic has a debt balance of 25.8 M EUR this year.
Biosenic Liabilities 2025
Biosenic Liabilities
25.8 M EUR
Ticker
BIOS.BR
ISIN
BE0974280126
WKN
A14NHV
In 2025, Biosenic's total liabilities amounted to 25.8 M EUR, a 0% difference from the 0 EUR total liabilities in the previous year.
Biosenic Aktienanalyse
What does Biosenic do?
Bone Therapeutics SA is a Belgian company specializing in the development of innovative therapies for bone and joint diseases. Its goal is to treat patients with severe orthopedic conditions and help improve their quality of life. The company's business model is based on extensive research and development strategies aimed at developing groundbreaking therapies for diseases such as fractures, osteoporosis, osteoarthritis, and other bone and joint-related conditions. It focuses on the development of innovative stem cell-based therapies that help repair damaged tissues and promote self-regeneration. Additionally, Bone Therapeutics has developed a special cell therapy called Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells, targeting cartilage growth as an alternative, cell-based therapy for knee and hip osteoarthritis. It has also developed a platform called Allogeneic Osteoblastic Cells, aiming to treat ligament and tendon injuries. The company conducts research and clinical studies in collaboration with academic partners to improve its therapies and develop new products and solutions. It operates in three business areas: Orthobiology, Cardiology, and Immunology, focusing on the development and marketing of therapies for bone and joint arthritis, cardiovascular diseases, and autoimmune diseases, respectively. Its current product offerings include Allob, AlgoScaff, and JTA-004 for the treatment of orthopedic conditions such as fractured vertebrae, severe bone injuries, bone regeneration, osteoporosis, and osteoarthritis. Bone Therapeutics is headquartered in Gosselies, Belgium, with offices in the US, France, Germany, and Italy. Its mission is to advance the development of therapies for bone and joint diseases and assist patients with severe orthopedic conditions. Through its research and development strategies, collaboration with academic partners, and strong market position, Bone Therapeutics aims to make a difference in the field. Biosenic ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Biosenic's Liabilities
Biosenic's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Biosenic's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Biosenic's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Biosenic's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Biosenic’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Biosenic stock
What were the liabilities of Biosenic compared to the previous year?
The liabilities of Biosenic have increased by 0% dropped compared to the previous year.
What are the consequences of high debt for investors of Biosenic?
High liabilities can pose a risk for investors of Biosenic, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Biosenic?
Low liabilities mean that Biosenic has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Biosenic affect the company?
An increase in liabilities of Biosenic can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Biosenic affect the company?
A decrease in the liabilities of Biosenic can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Biosenic?
Some factors that can influence the liabilities of Biosenic include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Biosenic so important for investors?
The liabilities of Biosenic are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Biosenic take to modify the liabilities?
To change its liabilities, Biosenic can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Biosenic pay?
Over the past 12 months, Biosenic paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Biosenic is expected to pay a dividend of 0 EUR.
What is the dividend yield of Biosenic?
The current dividend yield of Biosenic is .
When does Biosenic pay dividends?
Biosenic pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Biosenic?
Biosenic paid dividends every year for the past 0 years.
What is the dividend of Biosenic?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Biosenic located?
Biosenic is assigned to the 'Health' sector.
Wann musste ich die Aktien von Biosenic kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Biosenic from 6/23/2025 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 6/23/2025.
When did Biosenic pay the last dividend?
The last dividend was paid out on 6/23/2025.
What was the dividend of Biosenic in the year 2024?
In the year 2024, Biosenic distributed 0 EUR as dividends.
In which currency does Biosenic pay out the dividend?
The dividends of Biosenic are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Biosenic
Our stock analysis for Biosenic Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biosenic Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.